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Background: Seeking consent for genetic and genomic research can be challenging, particularly in populations
with low literacy levels, and in emergency situations. All of these factors were relevant to the MalariaGEN study of
genetic factors influencing immune responses to malaria in northern rural Ghana. This study sought to identify
issues arising in practice during the enrolment of paediatric cases with severe malaria and matched healthy
controls into the MalariaGEN study.
Methods: The study used a rapid assessment incorporating multiple qualitative methods including in depth
interviews, focus group discussions and observations of consent processes. Differences between verbal information
provided during community engagement processes, and consent processes during the enrolment of cases and
controls were identified, as well as the factors influencing the tailoring of such information.
Results: MalariaGEN participants and field staff seeking consent were generally satisfied with their understanding of
the project and were familiar with aspects of the study relating to malaria. Some genetic aspects of the study were
also well understood. Participants and staff seeking consent were less aware of the methodologies employed
during genomic research and their implications, such as the breadth of data generated and the potential for future
secondary research.
Moreover, trust in and previous experience with the Navrongo Health Research Centre which was conducting the
research influenced beliefs about the benefits of participating in the MalariaGEN study and subsequent decision-
making about research participation.
Conclusions: It is important to recognise that some aspects of complex genomic research may be of less interest
to and less well understood by research participants and that such gaps in understanding may not be entirely
addressed by best practice in the design and conduct of consent processes. In such circumstances consideration
needs to be given to additional protections for participants that may need to be implemented in such research,
and how best to provide such protections.
Capacity building for research ethics committees with limited familiarity with genetic and genomic research, and
appropriate engagement with communities to elicit opinions of the ethical issues arising and acceptability of
downstream uses of genome wide association data are likely to be important.
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The need for voluntary and informed consent to re-
search is enshrined in international guidance and regula-
tion on research ethics [1,2]. Consent processes for
research serve two purposes: first they are a means of
respecting participants’ autonomy and decision-making
capacity. Secondly, they can protect prospective partici-
pants by providing them with information about poten-
tial harms of research, and enabling them to choose to
avoid these by declining to take part in research.
Empirical research demonstrates that researchers en-
counter numerous challenges in practice when seeking to
implement consent processes that support potential re-
search participants in making voluntary and informed
decisions [3,4]. Particular challenges can arise when seek-
ing consent from impoverished populations with high
levels of illiteracy [5–7], when seeking consent to paediat-
ric research [8], when seeking consent to research in
emergency situations [9–11] and when seeking consent to
genomic research [12]. Specific challenges arising when
seeking consent for genetic and genomic research include
explaining the research methods, the implications of the
complex informatics infrastructure required to support
such studies and the potential consequences of future re-
search with samples and data (the nature of which may be
unknown at the time consent is sought)[13].
All of these factors were relevant in the recruitment of
participants into a case–control study to identify genetic
factors affecting immune responses to malaria under the
auspices of the MalariaGEN consortium [14]. In this
study the cases were children admitted to the Navrongo
War Memorial Hospital with diagnosis of severe malaria;
and the controls were drawn from healthy children in
the cases’ communities.
The MalariaGEN network incorporates large-scale
genome-wide association (GWA) studies to identify gen-
etic variants that are associated with resistance or sus-
ceptibility to severe malaria [15].
It compares genetic markers throughout the genomes
of patients with malaria (cases) and of healthy individuals
from the same populations (controls) to look for
differences between these groups that correlate with
resistance to disease [16]. This project has study sites in 11
malaria–endemic countries, including two sites in Ghana.
Data from individual study sites are used for genome-wide
analyses or for studying selected genetic variants. Malaria-
GEN releases the GWA data it generates to external
researchers for further analyses. To facilitate this process it
has developed a data release policy and data are released
via an Independent Data Access Committee [17].
There is a limited but growing literature on seeking
informed consent to research in developing countries
and a developing discourse on informed consent and
genomic research in developed countries [18–20]. Inresponse to challenges arising when seeking consent to
genomic research MalariaGEN developed a template and
guidelines for obtaining informed consent in consult-
ation with researchers and the ethics review committees
reviewing the study [21]. These materials were designed
to balance the need for fundamental human subject pro-
tections to be preserved across all of the malaria-
endemic sites where participants were being recruited,
while still allowing for appropriate tailoring of consent
processes to each research context.
We are aware of very few published empirical studies
on seeking consent for genetic or genomic research in
Africa [22–24]. The increasing interest in conducting
genomic research in Africa, such as that to be funded by
the Human Heredity and Health in Africa (H3 Africa)
initiative, suggests that such research is urgently needed.
The aim of our study was to examine the issues arising
when enrolling participants into a MalariaGEN project in
the Kassena-Nankana District (KND) in northern Ghana,
using consent materials adapted from the MalariaGEN
guidelines. Previous studies conducted in the KND on
informed consent and community engagement [5,25] have
described the role of traditional decision-making struc-
tures in the consent process, the role of trust in sustaining
researcher–participant relationship and some of the con-
straints of contextualizing current international consent
requirements. The focus of this study was to provide
insights into specific issues arising when seeking consent
to genetic and genomic research in a low-income context,
to identify examples of best practice in enrolling partici-
pants in this context, and to identify areas that may need
further research and discussion in this rural setting.
Rapid assessment methods were used to review the
initial design and conduct of the consent processes.
Ways in which consent processes were amended as
researchers and fieldworkers sought to achieve best
practice in enrolling participants were reviewed and par-
ticipants’ experiences and views of the research were
also sought. This paper concludes by discussing the po-
tential limitations of consent as a mechanism for legiti-
mising genomic research in a low income setting and
the additional measures to respect research participants
that it may be appropriate to implement in future gen-
etic and genomic studies in such contexts.
Methods
Rapid assessments are an established tool within the social
sciences designed to inform ‘the adaptation of interven-
tions to local cultures and conditions’ [26]. Assessments
are informed by an intensive data collection exercise
which employs multiple qualitative methods - such as par-
ticipant observation, semi-structured interviews, focus
group discussions and collection of unpublished data.
Data are then rapidly and iteratively analysed, and
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assessments has been proven valuable in other health-
related contexts in Africa [27] and calls have been made
for such assessments to be routinely conducted to inform
the design of consent processes before conducting trials in
developing countries [28,29]. Researchers have recently
demonstrated the value of using a rapid assessment to in-
form the design of a consent process for genetic research
in Ethiopia [23,24].
Study site
This study was conducted in the KND, one of the admin-
istrative districts of northern Ghana and the location of
the Navrongo Health Research Centre (NHRC). KND cov-
ers a land area of 1,675 km2 and has an estimated popula-
tion of 151,000. The two main ethnic groups that live in
the district are the Kassenas and Nankanis. Both groups
share a traditional rural agrarian culture and traditions
but speak different languages. In terms of traditional juris-
diction the KND is divided into Chiefdoms, headed by a
male Chief and a council of male elders representing vari-
ous communities. Within these traditional boundaries, the
Kassenas and Nankanis are grouped into compounds,
which are usually headed by the most elderly male. Com-
pounds are then further divided into households, in which
multiple generations of a family typically reside. The
current literacy rate in the KND is 59%.
The Navrongo Health Research Centre (NHRC) is
based in the KND and was established during a Vitamin
A supplementation trial (VAST), which was conducted
in 1989. The Centre is still colloquially known as ‘VAST’
rather than NHRC in the community.
The NHRC has also conducted research into diseases
such as malaria, HIV/AIDS, human rotavirus diarrhoea,
meningitis and lymphatic filariasis. The findings from a
number of NHRC trials, including the Vitamin A supple-
mentation trial, have influenced health service provision in
Ghana and internationally [30,31].
The NHRC contributes to MalariaGEN in collabor-
ation with the Noguchi Memorial Institute for Medical
Research in Accra, Ghana.
The MalariaGEN consent process
During the MalariaGEN study, information was provided to
prospective participants in three different ways. These were
a community engagement process prior to the initiation of
the study, a two-stage enrolment process for mothers or
caregivers of cases (children with severe malaria who pre-
sented at the hospital) and an enrolment process at the com-
munity level for matched controls (as illustrated in Figure 1).
Data collection
For this qualitative study, data were collected for six weeks
over a six month period, beginning in September 2008. Datacollection included face-to-face semi-structured interviews,
focus group discussions (FGDs) and observation of consent
processes for the MalariaGEN project. Information sheets,
consent forms, community entry statements and videos of
community meetings about the study were also reviewed.
The majority of the data analysed in this study came
from interviews and FGDs with research scientists, re-
search assistants, fieldworkers and parents of research
participants, as outlined below. The content of the inter-
views and FGDs was directed by a field guide that
addressed knowledge and understanding of the Malaria-
GEN study, the consent process, voluntariness and mo-
tivation for participation in research and future uses of
samples. Thirteen interviews were conducted in English
while eight interviews and the six FGDs were conducted
in the local languages of the participants.
To corroborate and expand on information gained
through the semi-structured interviews, a small number of
consent processes for enrolling cases and controls were
observed. The observers generated detailed field notes and
a debriefing session was later held with the participants to
discuss their experiences of the consent process.
This study was approved by the Oxford Tropical Re-
search Ethics Committee of the University of Oxford, UK
(ref 15 08) and Navrongo Health Research Centre’s Institu-
tional Review Board, Navrongo, Ghana (ref NHRCIRC074).
Sampling
The study incorporated purposive sampling of all the key
informants involved in the MalariaGEN project. The
MalariaGEN data fellow, the three clinicians caring for
study participants, an additional NHRC researcher, two
research assistants and four project staff at the hospital
recruiting cases and two fieldworkers recruiting controls
were interviewed. A sample of research participants
(mothers of cases or controls enrolled in the study within
the previous three months) were contacted sequentially
and invited to be interviewed or attend focus groups.
Written consent, which was preceded by a verbal explan-
ation of the study objectives and procedures, was obtained
from all participants in the study. The forms were also
translated into the two major local languages [Kasem and
Nankam] for non-English speaking participants, particu-
larly the mothers of the cases and controls. A total of 84
individuals participated in this study: 24 in face-to-face
semi-structured interviews and ten participants in each of
the six focus group discussions (see Table 1).
Data analysis
Data analysis was conducted iteratively throughout the
study. During the data collection period, preliminary
analysis of the initial interviews took place in KND and
the issues raised were further explored in subsequent
data collection. Interviews and FGDs conducted in local
Table 1 Research participants
Category Participants
Research scientists (male) 5 (interviews)
Research Assistants (male) 2 (interviews)
Research staff (2 male fieldworkers
recruiting controls and 4 female
project staff recruiting cases
in the wards)
6 (interviews)
Mothers of cases 34 (4 interviews and 3 focus
groups with 10 per group)
Mothers of controls 34 (4 interviews and 3 focus
groups with 10 per group)
Total number of participants 84
Community engagement 
Community entry meeting with chiefs and elders 








Brief discussion with child’s mother 
or carer about the purpose of 
blood-drawing 
Detailed discussion about research 
process with mother or carer when 
the child’s condition has improved 
Consent of parent or carer sought 






Brief discussion about purpose of visit 
with compound head and permission 
sought to enter compound 
Detailed discussion about research 
with household head (usually child’s 
father) and the child’s mother 
Consent of parent or guardian sought 
and documented 
Figure 1 Providing information to potential participants.
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were transcribed, anonymised and imported into qualita-
tive data analysis software (NVivo 8) for further analysis.
Results
The consent process
To obtain meaningful informed consent from study parti-
cipants requires the provision of information in a manner
that enhances participants’ understanding and appreci-
ation of relevant aspects of proposed research. Having a
well-written consent form does not guarantee participants’
understanding, particularly in populations with under-
developed local languages and high levels of illiteracy
which rely on verbal explanations about research. While
the consent forms used for the MalariaGEN study out-
lined all the salient aspects of the research, the research
team’s views about what information was most relevant to
the intended audience determined what information was
provided verbally at these three stages. Broadly speaking,
during the community engagement processes and the en-
rolment of controls at the community level there was
more space for discussions about genomic aspects of the
research than during recruitment of cases in the ward.
Engaging local communities in genomic research
In KND, the NHRC has established a model of engaging
local communities in research based on the traditional
practices of the Kassena-Nankana community [32]. As
reported by previous studies conducted in the KND [5,25],
traditionally, consultation with the gatekeepers of the com-
munity (chiefs and elders) is required before any researchis carried out in the community, followed by community
durbars (meetings) with the wider community. The Malar-
iaGEN study utilised these existing engagement processes.
We first of all went to talk to the chiefs and then told
them that this study is going to be conducted and
people would enter the community to talk to
community members and pick samples and . . . when a
child gets sick and comes to the ward and it’s severe
malaria disease this is what we are going to do [we
tried] to explain the study to them. (Research
Assistant)
The MalariaGEN research team reported that this com-
munity entry process aimed to seek permission from gate-
keepers of the community to conduct the study and to
inform the wider community about the proposed research
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ard community entry process had limitations because
women were infrequently involved in the process but had
an important role in consenting to research involving
young children in emergency situations (which frequently
involve severe malaria in this context) [25].
Consequently they went a step further than is usual
during community engagement exercises for NHRC
studies and organised meetings with women’s groups to
discuss the MalariaGEN study with them. In total five
large community durbars were held in addition to seven
smaller meetings with women’s groups.
During community meetings discussions covered the
purpose of the study, the procedures, who would be
involved and the expected outcomes of the study. Great
care was taken to explain scientific aspects of the re-
search and to translate complex information about
topics such as DNA and genes into lay local languages
with appropriate analogies to facilitate understanding.
. . .the thing in the blood that makes us different from
one another and can identify people from the same
family (Lay translation of genes during community
engagement)
Identifying research populations for community engage-
ment in advance for studies recruiting patients on admis-
sion to hospital can be challenging because of the size of
the catchment areas for such facilities. In such contexts
community engagement strategies such as the durbar have
limitations in terms of providing information to prospective
participants about the research in advance. However the
discussions at the end of the meetings reassured researchers
that the project was broadly acceptable to the community
and that aspects of genetic and genomic research could be
adequately explained to the population. Moreover prepar-
ing for, and reviewing the effectiveness of the provision of
information in community engagement meetings can pro-
vide a valuable means of rehearsing effective provision of
complex information during individual consent processes.
When we are doing the community meetings, that’s when
we give more information, we try to explain the science
aspects of these things, because you have the time to
explain and explain and explain. (Researcher)
The experience started with the community entry when
we tried to explain [the scientific terms]. The chiefs
would be laughing and then they try to give [us] the
appropriate word. (Fieldworker recruiting controls)
Enrolling cases in the hospital
The consent process for recruiting cases (children with
severe malaria) into the MalariaGEN study typicallyinvolved just the primary carer (usually the mother) who
brought a child with severe malaria to the hospital. Dis-
cussions about the study were held at least twice. On ad-
mission to the hospital, mothers were asked if blood
samples could be taken for both routine tests and poten-
tially for research into severe malaria. A single blood
draw was made for the purpose of clinical tests and
DNA extraction for the research.
A more detailed discussion about the study was held
subsequently if the child was eligible to participate. Sub-
sequent to that discussion, if the child’s parent agreed,
documentation for enrolment in the study would be
completed. Blood for patients who did not meet the re-
search criteria or whose primary care giver declined con-
sent was only used for clinical purposes.
[The nurses] can't just start taking the sample without
telling the mother what we are going to do or what we
are about. So from there we give some small summary
‘Excuse me I want to take some little blood from your
kid and I will talk to you later. . . and let you know
more about what is in the blood’. (Project staff
recruiting cases)
. . .when I went there with my child, it was in the
morning so the nurses and doctor attended to my
child. At that time the VAST workers were also there
so they all helped to set up the water before they came
and took the blood to go and test. (Focus group with
mothers of cases)
The research team highlighted the complexities of seek-
ing consent in hospital settings and especially in emergency
situations. When children are admitted with severe malaria
the priority is to provide appropriate treatment as rapidly
as possible. After recruiting the initial cases researchers
considered that it was practically impossible and ethically
inappropriate to conduct a detailed consent process for re-
search before collecting the samples needed for diagnosis
and treatment. Consequently the research team needed to
establish how to seek consent in a way that could
maximize understanding and free decision-making.
The revised process in place during the rapid assess-
ment involved project staff in charge of recruitment in the
paediatric ward observing the condition of the sick child
and the emotional state of the mother to ascertain an ap-
propriate time to initiate the consent process. Consent to
research was usually sought within 24 to 36 hours of ad-
mission. To protect privacy, mothers were invited to a pri-
vate room for the discussion, although some preferred to
discuss the research in the ward next to their child’s bed.
When the child is brought . . . [with] the convulsion the
child is weak, cannot open his eyes, the mother will be
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give the drugs, and the child can even talk or respond
to the mother, then she feels better, we can then do our
consenting. (Project staff recruiting cases)
There was consensus amongst the mothers interviewed
that it was appropriate in the circumstances for a discus-
sion of the project to take place after the blood samples
were collected and their child’s condition had stabilised.
They should take the blood first and when the child
gets better before they come to have the discussions
with [me]. (Mother of case)
In my case it was after my child felt better the
following day before they came and had the
discussions with me. If the girl [project staff] had come
on the day I brought the child I could not have
listened to her. (Mother of case)
While the parents we interviewed were generally satis-
fied with the timing of the consent process, some
mothers noted that they remained anxious about their
children when discussions about the project took place.
When she was discussing with me my attention was
there but my child’s illness was also on my mind.
(Mother of case)
Although the consent form covered all the salient
aspects of the research including the genetic component,
the focus of the discussions during the consent process
was the purpose of the study with an emphasis on the
rationale for blood-taking. Discussions about malaria
genetics were phrased in general terms: ‘the thing in the
blood that makes your child sick and other children of
the same age group not sick’.
Then we’ll tell her that we will go to her area to take
about two children of the same age and same sex,
everything. Those two children must be healthy as
well, then we’ll test to [confirm] whether those children
are having this sickness. If it happens that they are
not, then we will try to know why they’re in the same
area and this one has [malaria] while that one is not
having it. (Project staff recruiting cases)
Enrolling controls in the community
Following enrolment of a case, fieldworkers visited the
case’s community to enrol a matched ‘healthy’ control (a
child whose parents answered ‘Yes’ to the question ‘Is your
child well today?’). Enrolling controls involved a traditional
multi-layered process where the permission of the head of
the compound as well as the head of the household wassought before parents were approached. Fieldworkers noted
that it was important for all levels of authority to under-
stand the selection criteria for controls and appreciate why
a particular child in their compound was selected.
Traditionally, around here, before you go into
somebody’s house you have to greet, so what we do is
. . . seek permission to enter into the house from the
compound head. So you tell the person of your
mission, who you are, where you are coming from and
what jobs you want to do in his compound, who you
are looking for, let that person understand how you got
that person’s name. (Fieldworker recruiting controls)
Discussions about purpose of the visit with compound
heads ranged from brief to lengthy, depending on the
compound head’s interest in the research. Detailed discus-
sions about the research were then held with household
heads and parents. In contrast to cases in the hospital
ward, parents of controls often had more leisure to con-
sider participation and wanted more detail about why
researchers sought to enrol one of their healthy children
in a study. In such circumstances fieldworkers discussed
the scientific rationale of the research in further detail.
Researchers feel that probably it is something to do
with human genes because probably you have two
people living in the same area. . . one is always sick
with malaria but the other isn’t sick with malaria.
When you take them to the laboratory to have a
malaria test you might find out that the one that is
not sick with malaria has got the malaria parasite,
more than one who’s always ill. That means that it is
something to do with our genes. Probably the other
person's DNA or gene is different from yours, maybe it
is stronger, so that fights the malaria though he has
the parasite. (Fieldworker recruiting controls)
Data from fieldworkers illustrated that an important
issue when enrolling controls was explaining why blood
samples from healthy children were being sought.
What is unusual is that we go to take [blood from] the
controls and not from a sick child but from a healthy
child and we are taking blood samples because when
your child is sick and you are taking blood you know
you are coming for help but my child is not sick and
you are coming for blood it is a problem! (Fieldworker
recruiting controls)
Fieldworkers explained that an extensive explanation
of the rationale for taking these samples often helped to
allay concerns parents might have about this process
and refusals to take part in the research were rare.
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research
Findings from this study demonstrated that in addition to
senior researchers and research assistants; project staff,
fieldworkers and parents of cases and controls had a good
level of comprehension of aspects of the MalariaGEN pro-
ject relating to malaria, which is a familiar disease in KND.
In contrast, levels of understanding of the complex and
unfamiliar topic of genetic research varied considerably
amongst staff and participants. Fieldworkers enrolling con-
trols, research assistants and researchers were familiar with
the methods used in the study to identify genetic differences
between cases and controls which may correlate to suscep-
tibility or resistance to severe malaria. Project staff recruit-
ing cases, and mothers of cases and controls demonstrated
less understanding of the methods used in the study.
They said if I got home, they would visit our
compound to get other three children and my child,
take their blood sample and my child’s blood sample
to compare and see whether their malaria is the same
or not. If it is not the same, they have to know why my
child’s and theirs is not the same. I don’t understand
that aspect of it. (Focus group with mothers of cases)
Additionally, the research team clearly recognised the
difficulty in explaining genomics in local languages and
the need to identify innovative ways of explaining the
'essential characteristics' of the genomic research to par-
ticipants. In general, how much of the science to com-
municate, given these limitations, remained a challenge
at all stages of the engagement process.
It is very challenging because, the language is pretty
much undeveloped, there is no. . . terminology for those
things, you need to explain them. . . if I were to write
how I would explain a gene [in a local language], it is
probably like a page, just for one word. (Researcher)
We don’t have a term, a single word that we can use
to say genes, and so you talk about the blood and then
you talk about the individual differences, we say that
there are certain things in your blood that bring about
our individual differences and that is what we want to
extract. So with this they actually are able to
understand. (Research Assistant)
Mothers were aware that the MalariaGEN project was
aimed at gaining knowledge about malaria to facilitate the
discovery of effective treatment. They understood that the
project method involved recruiting severely ill children at
the hospital as well as healthy children in the community.
Mothers understood the rationale of the MalariaGEN pro-
ject in terms of looking at the children’s blood to finddifferences which could explain why some children got se-
vere malaria and others did not. However, they did not en-
gage with the scientific methods by which this would be
done, and the implications of that are discussed in the fol-
lowing section.
When they were recruiting us for the study they told me
my child has too many parasites and that a team from
VAST [NHRC] was coming to conduct a study on
malaria so I can decide to be part. . . they said also that,
they will send down some people to come to our
community, recruit a child who doesn’t have the malaria
and repeat the same process to find out why that child
doesn’t have and my child has. (Mother of case)
You know there is a kind of malaria that can attack a
child and make him collapse; he did not see that
happen to our children so he wanted to know why that
did not happen to our children. (Mother of control)
Most mothers could understand a discussion about the
genetics of malaria because they related genetics to hered-
ity based on their experiences of diseases that run in fam-
ilies. However, extending this understanding to the
broader concept of genomics was more challenging. It
was particularly difficult to extrapolate mothers’ know-
ledge of heredity to explain genomics where such research
involves population level sampling that does not necessar-
ily involve families affected by the disease under study.
Sample use and data sharing
One consequence of participants’ understanding the
methods of a genomic study in general terms is the diffi-
culty of explaining potential downstream consequences
of data sharing and analysis. Researchers and fieldwor-
kers discussed the complexities of explaining the ration-
ale for multiple uses of samples and data, a common
feature of genomic research:
The other difficulty is when you want to talk about data
access. Data access in a community that does not
appreciate computers. . .we have to have innovative ways
of doing that. You know one time I was talking about
data access in the durbar and then the question that
came up was is it wireless, is it like TV? (Researcher)
The MalariaGEN Network has developed a data release
policy in conjunction with the ethics committees govern-
ing research in communities donating samples [17]. This
policy provides for controlled release of genomic data to
legitimate external researchers for acceptable research
purposes. In this study we attempted to explore issues re-
lating to the acceptability of future uses of data. Given that
the participants were not familiar with scientific methods
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uses could not focus on genomic data. Nonetheless some
exploration of this topic was considered desirable.
During some of the FGDs and interviews questions were
couched in broad terms and focussed on a more familiar
and related topic of secondary sample use, such as: ‘When
they use the blood for a study there may be some left over
and an idea could come up for a new study. Would you
say they should ask you before using the left over blood
for the new study or should they continue working with
it?’. Participants indicated that researchers could conduct
ongoing studies with left over samples without seeking
additional permission from sample donors.
I think such an idea is not bad because they want to
research into finding new solutions to solve our health
problems. (Focus group with mothers of cases)
If they will be able to research into new solutions, it
will be beneficial to us. So we have no problem with
that. (Focus group with mothers of cases)
In addition, some participants asked that they be con-
tacted if relevant findings were generated, a topic con-
sidered further below in the discussion about boundaries
between research and therapy.
To me when there is a leftover they can use it if in future
there is a study, but they should get me informed later
maybe to tell me the results. (Mother of case)
Boundaries between research and therapy
An additional factor impacting on participants’ under-
standings of the MalariaGEN study and their decisions
about participation were beliefs about the benefits of
study participation and the widespread conception that
research studies are for the benefit of participants. There
is a wealth of literature on this latter belief, sometimes
termed ‘therapeutic misconception’ which has been
demonstrated in many countries [7,33–35] and high-
lighted as a concern in genomic research [36].
In most clinical trials conducted by the NHRC, research
participants have access to free health care services for
problems unrelated to the research and medical bills of re-
search participants are often covered by the research team.
The community is familiar with this process.
I have another child who ever participated in one of
their studies; it was they who took care of the child to
be healthy. I know how good it is. (Focus group with
mothers of cases)
Consequently, although in the MalariaGEN study re-
search participants’ parents were not informed prior toconsenting that their hospital costs would be met if they
took part in the project, study responses revealed that par-
ticipants’ unmet needs and parents’ expectations of free
medical care for their children were important motivating
factors for participation. Some mothers’ phrasing sug-
gested that although they had been told research partici-
pation was optional; in practice the benefits of research
participation were perceived to be so great that it would
be hard to decline the study, a feature also reported in
other African contexts [7,37,38].
When the [project staff member] came he did not force
us; he said whoever wanted could participate in it. I
saw that it was beneficial; there are so many diseases
and since they came to help us (the community), you
had to agree . . . (Mother of control)
She said it was not compulsory, if you did not want to
participate, you could refuse; I wanted to participate
that was why I thumb printed. This is one of the
papers, she said it was voluntary and I knew it would
be beneficial to me. (Mother of case)
Comments from these mothers consistently suggested
that they didn’t clearly distinguish between the different
research projects conducted by the NHRC (or VAST as
it is colloquially known), or where such distinctions are
made, different types of studies are perceived to offer
similar benefits, such as free healthcare for a certain
period of time during the study.
My child always falls sick and anytime I send him
there he was treated free under VAST. That is why I
agreed to participate in this study too. (Mother of case)
Unlike some studies where it is not clear that partici-
pants are aware that there is a distinction between re-
search and therapy, [34] in KND the NHRC is well
known and parents of cases clearly understood they
were participating in research and could distinguish be-
tween project staff and hospital staff.
The nurses wear white and blue; VAST workers wear
mufti; that is how we know these are nurses and these
are VAST workers (Focus group with mothers of cases)
I know where the VAST workers sit, where the nurses
sit and even the doctor’s room. (Focus group with
mothers of cases).
Although clearly distinguishing between research and
healthcare staff, mothers of cases and controls were gen-
erally of the view that the work of NHRC is to help them
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beneficial to participate in the research.
I said if it was something that was not beneficial to our
community, they would not have done it and since he
wanted to recruit our children into the study, it would
be beneficial to them. (Focus group with mothers of
controls)
It was because malaria attacked other children
around but did not attack my child; that was why I
agreed so that the disease would not worry my child.
(Mother of control)
This study demonstrates that participants’ views of
NHRC, and their expectations of the benefits of research
(based on their previous experiences NHRC and not just
information provided to them during the consent process
for the MalariaGEN study) are important factors in their
decision-making. Consequently, even studies that do not
offer direct benefits to participants, such as the Malaria-
GEN study, may be perceived as offering such benefits.
Discussion
The complexity of genomic research has meant that in one
such study participants were considered to require a Mas-
ters qualification in genetics or equivalent before having
the capacity to properly appreciate the risks of being
involved and to give informed consent [39]. In African gen-
omic studies incorporating large population groups and
disease cohorts the majority of participants involved are
unlikely to have a substantial background knowledge of
genetics and their understanding of the research will ne-
cessarily be affected [22,24]. In contexts such as KND in
northern Ghana, populations may also have relatively low
literacy rates and limited familiarity with many of the con-
cepts involved in biomedical research and the information
technology required for the management of genomic data.
Nyika cautions against exaggerating the impact of illiteracy
on understanding information in developing countries
about research and urges researchers to make extra efforts
to address the challenges of seeking consent to genetic and
genomic research in developing countries [40].
Determining best practice in seeking consent given the
constraints faced in various research contexts will always
be a challenge for researchers. In the KND, previous
studies [5,25] have reported some of these constraints
which relate to enhancing general understanding of re-
search. Our current study indicates that in the context
of genetic and genomic research, which involve complex
scientific research methodologies, the consent process
can be further complicated by difficulties with making
the scientific concepts comprehensible to staff seeking
consent as well as to research participants.NHRC researchers noted that explanations of genomic
aspects of research are likely to be particularly time con-
suming for participants, given literacy levels and the lim-
itations of local languages for explaining such concepts,
a factor commented on by researchers in other develop-
ing country contexts [36,41].
Another constraint highlighted in this study is the con-
duct of research in emergency situations which may make
standard consent processes impracticable. The findings
from this study provide examples of researchers’ responses
to such constraints such as the care taken during commu-
nity engagement exercises to develop ways of explaining
genomic concepts and incorporating a two stage consent
process to facilitate understanding in emergency situa-
tions. This study also identified factors that could improve
understanding in future genomic research. One example
is providing additional specialised training to research staff
seeking consent for such a complex topic and ensuring
that the lessons learned by such staff are communicated
to those seeking consent for future genomic studies.
Variations in knowledge and understanding of genomics
amongst staff recruiting participants in the MalariaGEN
study could be attributed to the training they have received
on this topic and their prior experience of other genetic
studies. Both project staff on the wards enrolling cases and
fieldworkers enrolling controls had secondary education
and experience of enrolling participants in other case–con-
trol and genetic studies prior to the MalariaGEN study. The
training they received for enrolling participants in this
MalariaGEN study included exercises on explaining the
genetic aspect of the research. In contrast to project staff
on the wards, fieldworkers not only received additional
training about genetic aspects of research as a consequence
of recruiting participants into more than one MalariaGEN
study, they also had more opportunity to rehearse the
provision of information on these topics during the consent
processes for healthy controls at the community level and
during community engagement exercises.
More than one factor may have contributed to the fact
project staff did not discuss genetics in detail when
explaining the rationale of the research to cases’ mothers.
One consideration is that they did not receive the add-
itional training sessions about genetic aspects of research
that fieldworkers did and may not have felt as comfortable
explaining the research methods as a result. Additionally
project staff were very aware that parents of cases on the
ward were still under some stress and did not want to
spend a disproportionate amount of time on consent, so
they focused on topics considered of most importance to
parents, such as the purposes of blood-taking.
Our findings suggest that while specialised training of
experienced research staff could improve communication
about the genomic methods of the research during the
consent process, this will not necessarily be a topic of
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may not be willing to spend additional time needed to
understand the genomic nature of the research as opposed
to those aspects of more interest, such as tangible risks
and benefits of research participation. Previous experi-
ences with the research institutions such as the NHRC
and its researchers may also be important factors in
decision-making, and have more influence on decision-
making than information about a specific study. For ex-
ample, we found that trust and the expectation of health
benefits were important factors in the mothers’ decision
to enrol their children in the MalariaGEN study.
Our data showed that participants’ parents understood
the purpose of the MalariaGEN study as finding out why
some children got severe malaria while others in similar
environments didn’t. They were less familiar, however,
with the methods that would be used to find this infor-
mation, although they were aware that it would involve
examining participants’ blood, and in some cases knew
that it would be inheritable factors in the blood that
make each person different that would be examined.
Greater familiarity with the purpose of malaria research
than the techniques that would be involved has also
been found in rural Uganda [42] and Tekola and collea-
gues demonstrated similar levels of understanding of the
genetic nature of research in rural Ethiopia [23].
A consequence of these levels of understanding is that
participants will have little conception of the potential
downstream uses of genomic data generated from their
samples. As discussed in the results section, mothers
expressed some support for the idea of reusing research
samples in further studies. Similar findings were found in
rural Uganda where 95% of participants in research agreed
that further research could be conducted on linked sam-
ples with ethics committee permission, without returning
to participants for further consent [42]. We believe that
further research is needed to address the ethical issues
arising in future uses of stored samples and getting a dee-
per understanding of the meanings behind participants’
responses to these issues.
Furthermore, some of us have argued elsewhere that a gov-
erned approach to data sharing is desirable and appropriate
in response to the challenges in obtaining consent for gen-
omic studies in Africa [17]. As the biomedical research enter-
prise increasingly incorporates complex scientific research
methodologies, such as those involved in genomic research,
there may be a need to focus more attention on additional
protection mechanisms for research participants such as
community engagement exercises and strengthening the re-
view processes involved in these types of research projects.
Limitations
This initial study aimed to identify issues arising when
seeking consent to genetic and genomic research in arural African context. As with other qualitative studies
of this nature, the relevance of the findings to other re-
search contexts requires further investigation, although a
comparison with the published literature above suggests
that some of the issues identified have relevance in other
research contexts. It was beyond the scope of this study
to include a comprehensive assessment of potential fac-
tors influencing understanding of genomic research in
this population, such as low literacy levels and further
research of this nature is likely to be valuable.
A specific limitation of this study is that it used ques-
tions about further research on identifiable blood sam-
ples as a proxy to begin exploring concerns about future
research using genomic data. This is not ideal as the
issues arising are related but not identical: some con-
cerns raised by participants and fieldworkers had limited
relevance to analysis of anonymised genomic data, such
as linking potentially stigmatising results of novel re-
search (including HIV status) to identifiable samples.
Other issues that would require a familiarity with the
complexities of analysis of anonymised genomic data
were not expressed, such as the potential for such data
to be stored and reused indefinitely.
Additionally, if not carefully thought through in ad-
vance, the phrasing of questions about blood samples
could sometimes give the misleading and potentially up-
setting impression that there will always be blood left over
from the research. This may lead to concerns amongst
parents about the amounts of blood taken for research
and potential uses that may be made of ‘surplus’ blood.
Following recent controversy about unanticipated genetic
research being conducted with Havasupai samples in the
US, further empirical research to determine attitudes to
ongoing uses of samples and data from specific communi-
ties is desirable [43].
Finally, since this research was focused on the Malaria-
GEN project, we purposively recruited all the research-
ers, research assistants and research staff of the project
in this study who gave consent for their inclusion in the
study. The number of people in each category was lim-
ited by the number of researchers and research assis-
tants working at the Navrongo Health Research Centre.
Conclusions
Genomic research is a rapidly expanding field of research
with which many researchers, field staff and ethical review
committees have limited experience. For all these groups
further education about the complex and sometimes novel
ethical issues raised by such studies, and their implications
for the design of appropriate methods for engaging with
relevant research populations before, during and after
genomic research will be necessary for the design and im-
plementation of such research. This study demonstrates
the importance of ensuring that resources are available for
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even for research teams that have significant experience in
other forms of healthcare research.
In light of the issues discussed above about difficulties
arising when seeking consent to genomic research, we con-
clude that careful consideration needs to be given to add-
itional protections for participants that may need to be
implemented in such research, and how best to provide
such protections. Capacity building for local ethics com-
mittees to enable appropriate consideration of ethical
issues raised by genomic research is likely to be necessary
in many contexts with limited experience of this form of
research. Care will also be needed to determine the roles
and responsibilities of local ethics committees and commu-
nity representatives in contributing to the ongoing govern-
ance of genomic resources derived from their populations.
An additional important measure may be to ensure
that community engagement activities are routinely con-
ducted before, during and after, genomic research, as in
the International HapMap Project. [44,45]. Even where
the communities to be enrolled in research cannot be
identified in advance, community engagement activities
may provide a chance for researchers to consult about
important aspects of genomic studies, including topics
such as potential future uses of genomic data. Such ac-
tivities can provide insights into community views on
more complex and abstract aspects of research that, if
appropriately documented, can inform both the design
of consent processes and the decisions of community
representatives and local ethics committees involved in
ongoing governance of genomic resources. Further re-
search is needed to determine how to appropriately en-
gage with communities to elicit informed opinions of
the acceptability of downstream uses of genome wide as-
sociation data and other potential ethical issues.
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